These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4059655

  • 1. Fibrinolytic activity of immobilized plasminogen activator.
    Senatore FF, Bernath FR.
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antithrombotic mechanisms of urokinase immobilized polyurethane.
    Kitamoto Y, Tomita M, Kiyama S, Inoue T, Yabushita Y, Sato T, Ryoda H, Sato T.
    Thromb Haemost; 1991 Jan 23; 65(1):73-6. PubMed ID: 2024241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Jun 30; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 10. Urokinase bound to fibrocollagenous tubes: an in vitro kinetic study.
    Senatore FF, Bernath FR.
    Biotechnol Bioeng; 1986 Jan 30; 28(1):58-63. PubMed ID: 18553842
    [Abstract] [Full Text] [Related]

  • 11. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN, Lee SC, Jackson KW, Tae WC, Schwartzott DG, McKee PA.
    Thromb Haemost; 1998 Oct 30; 80(4):637-44. PubMed ID: 9798984
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Water-soluble modified derivatives of urokinase: fibrinolytic activity and other properties].
    Maksimenko AV, Torchilin VP.
    Vopr Med Khim; 1985 Oct 30; 31(4):12-20. PubMed ID: 4049780
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Oct 30; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
    Collen D, Stassen JM, Blaber M, Winkler M, Verstraete M.
    Thromb Haemost; 1984 Aug 31; 52(1):27-30. PubMed ID: 6541817
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G, Noring R, Klempner MS.
    Biochem Biophys Res Commun; 1996 Feb 27; 219(3):690-5. PubMed ID: 8645243
    [Abstract] [Full Text] [Related]

  • 20. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
    Lijnen HR, De Wreede K, Demarsin E, Collen D.
    Thromb Haemost; 1984 Aug 31; 52(1):31-3. PubMed ID: 6495261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.